NVNO vs. EW

Last updated Apr 2, 2026

Compare and contrast key facts about enVVeno Medical Corporation (NVNO) and Edwards Lifesciences Corporation (EW).

Performance

NVNO vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in enVVeno Medical Corporation (NVNO) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

NVNO vs. EW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
NVNO enVVeno Medical Corporation	-8.27%	-89.38%	-41.25%	0.78%	-22.61%	-23.82%	-37.09%	-62.71%	-71.85%
EW Edwards Lifesciences Corporation	-4.68%	15.16%	-2.91%	2.20%	-42.41%	42.00%	17.32%	52.31%	11.55%

Fundamentals

Market Cap NVNO : $6.07M EW : $47.28B
EPS NVNO : -$93.91 EW : $1.83
PB Ratio NVNO : 0.22 EW : 4.57
Total Revenue (TTM) NVNO : $0.00 EW : $6.07B
Gross Profit (TTM) NVNO : -$372.00K EW : $4.74B
EBITDA (TTM) NVNO : -$19.38M EW : $1.35B

Returns By Period

In the year-to-date period, NVNO achieves a -8.27% return, which is significantly lower than EW's -4.68% return.

NVNO

• 1D: 1.68%
• 1M: 1.08%
• YTD: -8.27%
• 6M: -67.68%
• 1Y: -88.46%
• 3Y*: -60.23%
• 5Y*: -46.65%
• 10Y*: —

EW

• 1D: 1.47%
• 1M: -6.79%
• YTD: -4.68%
• 6M: 6.49%
• 1Y: 13.07%
• 3Y*: -0.60%
• 5Y*: -0.62%
• 10Y*: 10.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NVNO vs. EW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVNO

NVNO Risk / Return Rank: 10
NVNO Sharpe Ratio Rank: 10
NVNO Sortino Ratio Rank: 9
NVNO Omega Ratio Rank: 7
NVNO Calmar Ratio Rank: 5
NVNO Martin Ratio Rank: 16

EW

EW Risk / Return Rank: 58
EW Sharpe Ratio Rank: 60
EW Sortino Ratio Rank: 54
EW Omega Ratio Rank: 51
EW Calmar Ratio Rank: 62
EW Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVNO vs. EW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for enVVeno Medical Corporation (NVNO) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVNO	EW	Difference
Sharpe ratio Return per unit of total volatility	-0.73	0.55	-1.27
Sortino ratio Return per unit of downside risk	-1.09	0.98	-2.07
Omega ratio Gain probability vs. loss probability	0.83	1.11	-0.29
Calmar ratio Return relative to maximum drawdown	-0.93	0.95	-1.88
Martin ratio Return relative to average drawdown	-1.25	2.63	-3.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVNO vs. EW - Sharpe Ratio Comparison

The current NVNO Sharpe Ratio is -0.73, which is lower than the EW Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of NVNO and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NVNO	EW	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.73	0.55	-1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.58	-0.02	-0.56
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.32	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.57	0.51	-1.09

Correlation

The correlation between NVNO and EW is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVNO vs. EW - Dividend Comparison

Neither NVNO nor EW has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NVNO vs. EW - Drawdown Comparison

The maximum NVNO drawdown since its inception was -99.81%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for NVNO and EW.

Drawdown Indicators

	NVNO	EW	Difference
Max Drawdown Largest peak-to-trough decline	-99.81%	-54.32%	-45.49%
Max Drawdown (1Y) Largest decline over 1 year	-95.28%	-12.73%	-82.55%
Max Drawdown (5Y) Largest decline over 5 years	-97.66%	-54.32%	-43.34%
Max Drawdown (10Y) Largest decline over 10 years	—	-54.32%	—
Current Drawdown Current decline from peak	-99.78%	-37.82%	-61.96%
Average Drawdown Average peak-to-trough decline	-89.75%	-14.31%	-75.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	70.94%	4.61%	+66.33%

Volatility

NVNO vs. EW - Volatility Comparison

enVVeno Medical Corporation (NVNO) has a higher volatility of 24.63% compared to Edwards Lifesciences Corporation (EW) at 7.95%. This indicates that NVNO's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVNO	EW	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.63%	7.95%	+16.68%
Volatility (6M) Calculated over the trailing 6-month period	81.30%	17.43%	+63.87%
Volatility (1Y) Calculated over the trailing 1-year period	121.78%	24.02%	+97.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.30%	32.49%	+48.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	94.32%	32.59%	+61.73%

Financials